Literature DB >> 22882890

Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death.

Marjorie A Rosenberg1, Eric J Feuer, Binbing Yu, Jiafeng Sun, S Jane Henley, Thomas G Shanks, Christy M Anderson, Pamela M McMahon, Michael J Thun, David M Burns.   

Abstract

The purpose of this study was to develop life tables by smoking status removing lung cancer as a cause of death. These life tables are inputs to studies that compare the effectiveness of lung cancer treatments or interventions, and provide a way to quantify time until death from causes other than lung cancer. The study combined actuarial and statistical smoothing methods, as well as data from multiple sources, to develop separate life tables by smoking status, birth cohort, by single year of age, and by sex. For current smokers, separate life tables by smoking quintiles were developed based on the average number of cigarettes smoked per day by birth cohort. The end product is the creation of six non-lung-cancer life tables for males and six tables for females: five current smoker quintiles and one for never smokers. Tables for former smokers are linear combinations of the appropriate table based on the current smoker quintile before quitting smoking and the never smoker probabilities, plus added covariates for the smoking quit age and time since quitting.
© 2011 Society for Risk Analysis.

Entities:  

Mesh:

Year:  2012        PMID: 22882890      PMCID: PMC3594098          DOI: 10.1111/j.1539-6924.2011.01662.x

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  5 in total

1.  On the comparable quantification of health risks: lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Epidemiology       Date:  1999-09       Impact factor: 4.822

2.  Competing risks to breast cancer mortality.

Authors:  Marjorie A Rosenberg
Journal:  J Natl Cancer Inst Monogr       Date:  2006

3.  Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.

Authors:  Pamela M McMahon; Alan M Zaslavsky; Milton C Weinstein; Karen M Kuntz; Jane C Weeks; G Scott Gazelle
Journal:  Med Decis Making       Date:  2006 Sep-Oct       Impact factor: 2.583

4.  Mortality from smoking worldwide.

Authors:  R Peto; A D Lopez; J Boreham; M Thun; C Heath; R Doll
Journal:  Br Med Bull       Date:  1996-01       Impact factor: 4.291

5.  Mortality from cancer in relation to smoking: 50 years observations on British doctors.

Authors:  R Doll; R Peto; J Boreham; I Sutherland
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

  5 in total
  35 in total

1.  The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes.

Authors:  David T Levy; K Michael Cummings; Bryan W Heckman; Yameng Li; Zhe Yuan; Tracy T Smith; Rafael Meza
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

2.  Differences in Cancer Survival with Relative versus Cause-Specific Approaches: An Update Using More Accurate Life Tables.

Authors:  Gonçalo Forjaz de Lacerda; Nadia Howlader; Angela B Mariotto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-20       Impact factor: 4.254

3.  Patterns of birth cohort-specific smoking histories, 1965-2009.

Authors:  Theodore R Holford; David T Levy; Lisa A McKay; Lauren Clarke; Ben Racine; Rafael Meza; Stephanie Land; Jihyoun Jeon; Eric J Feuer
Journal:  Am J Prev Med       Date:  2014-02       Impact factor: 5.043

4.  Modeling smoking-attributable mortality among adults with major depression in the United States.

Authors:  Jamie Tam; Gemma M J Taylor; Kara Zivin; Kenneth E Warner; Rafael Meza
Journal:  Prev Med       Date:  2020-08-27       Impact factor: 4.018

5.  A Decision Analysis of Follow-up and Treatment Algorithms for Nonsolid Pulmonary Nodules.

Authors:  Mark M Hammer; Lauren L Palazzo; Andrew L Eckel; Eduardo M Barbosa; Chung Yin Kong
Journal:  Radiology       Date:  2018-11-20       Impact factor: 11.105

6.  Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Authors:  Kevin Ten Haaf; Harry J de Koning
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

7.  Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.

Authors:  Rafael Meza; Kevin ten Haaf; Chung Yin Kong; Ayca Erdogan; William C Black; Martin C Tammemagi; Sung Eun Choi; Jihyoun Jeon; Summer S Han; Vidit Munshi; Joost van Rosmalen; Paul Pinsky; Pamela M McMahon; Harry J de Koning; Eric J Feuer; William D Hazelton; Sylvia K Plevritis
Journal:  Cancer       Date:  2014-02-27       Impact factor: 6.860

8.  Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy.

Authors:  David van Klaveren; John B Wong; David M Kent; Ewout W Steyerberg
Journal:  Med Decis Making       Date:  2017-03-20       Impact factor: 2.583

9.  Chapter 8: The FHCRC lung cancer model.

Authors:  William D Hazelton; Jihyoun Jeon; Rafael Meza; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

10.  Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.

Authors:  Pamela M McMahon; Chung Yin Kong; Bruce E Johnson; Milton C Weinstein; Jane C Weeks; Angela C Tramontano; Lauren E Cipriano; Colleen Bouzan; G Scott Gazelle
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.